tiprankstipranks
Advertisement
Advertisement

ALDX Stock Latest News

Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support
Company AnnouncementsAldeyra Therapeutics Adds Independent Director, Affirms Governance Support
1M ago
8K
ALDX
Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims
PremiumMarket News
Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims
2M ago
ALDX
Aldeyra Updates Reproxalap Outlook and Extends Cash Runway
PremiumCompany Announcements
Aldeyra Updates Reproxalap Outlook and Extends Cash Runway
3M ago
8K
ALDX
Aldeyra Therapeutics Faces Securities Lawsuit Over Reproxalap Trial Disclosures 
PremiumClass Action
Aldeyra Therapeutics Faces Securities Lawsuit Over Reproxalap Trial Disclosures 
3M ago
ALDX
Aldeyra Therapeutics Announces Upcoming Board Member Departure
PremiumCompany Announcements
Aldeyra Therapeutics Announces Upcoming Board Member Departure
3M ago
8K
ALDX
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
PremiumClass ActionALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
3M ago
ALDX
Aldeyra Therapeutics Sued Over Alleged Misrepresentations About Key Drug Trial Data
Premium
Class Action
Aldeyra Therapeutics Sued Over Alleged Misrepresentations About Key Drug Trial Data
4M ago
ALDX
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility
Premium
Company Announcements
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility
4M ago
8K
ALDX
Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds
PremiumRatings
Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds
4M ago
ALDX
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
4M ago
ALDX
Morning News Wrap-Up 3/17/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 3/17/26: Today’s Biggest Stock Market Stories!
4M ago
MA
MU
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
PremiumThe Fly
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
4M ago
ALDX
How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?
PremiumMarket NewsHow Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?
4M ago
ALDX
FDA Issues Second Complete Response Letter for Reproxalap
Premium
Company Announcements
FDA Issues Second Complete Response Letter for Reproxalap
4M ago
8K
ALDX
Aldeyra options imply 10.9% move in share price post-earnings
Premium
The Fly
Aldeyra options imply 10.9% move in share price post-earnings
5M ago
ALDX
Aldeyra Therapeutics Announces Chief Development Officer Resignation
PremiumCompany Announcements
Aldeyra Therapeutics Announces Chief Development Officer Resignation
7M ago
8K
ALDX
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Drug Development and Robust Investment Potential
PremiumRatings
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Drug Development and Robust Investment Potential
7M ago
ALDX
Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
PremiumThe Fly
Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
7M ago
F
F
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
PremiumRatings
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
7M ago
ALDX
Unusually active option classes on open December 16th
PremiumThe FlyUnusually active option classes on open December 16th
7M ago
F
BP
Aldeyra Therapeutics Faces FDA PDUFA Date Extension
Premium
Company Announcements
Aldeyra Therapeutics Faces FDA PDUFA Date Extension
7M ago
8K
ALDX
Aldeyra announces PDUFA extension for Reproxalap
Premium
The Fly
Aldeyra announces PDUFA extension for Reproxalap
7M ago
ALDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >